Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Edith González-González"'
Autor:
Silvia Godínez-Palma, Edith González-González, Frida Ramírez-Villedas, Circe Garzón-Guzmán, Luis Vallejo-Castillo, Gregorio Carballo-Uicab, Gabriel Marcelín-Jiménez, Dany Batista, Sonia M. Pérez-Tapia, Juan C. Almagro
Publikováno v:
Viruses, Vol 15, Iss 8, p 1733 (2023)
We recently reported the isolation and characterization of an anti-SARS-CoV-2 antibody, called IgG-A7, that protects transgenic mice expressing the human angiotensin-converting enzyme 2 (hACE-2) from an infection with SARS-CoV-2 Wuhan. We show here t
Externí odkaz:
https://doaj.org/article/57e408d4590946ba8093fcf74626051e
Autor:
Edith González-González, Gregorio Carballo-Uicab, Juana Salinas-Trujano, María I. Cortés-Paniagua, Said Vázquez-Leyva, Luis Vallejo-Castillo, Ivette Mendoza-Salazar, Keyla Gómez-Castellano, Sonia M. Pérez-Tapia, Juan C. Almagro
Publikováno v:
Antibodies, Vol 11, Iss 3, p 57 (2022)
Neutralizing antibodies targeting the receptor-binding domain (RBD) of SARS-CoV-2 are among the most promising strategies to prevent and/or treat COVID-19. However, as SARS-CoV-2 has evolved into new variants, most of the neutralizing antibodies auth
Externí odkaz:
https://doaj.org/article/6ab45ea8f6a64fbeab56537432b35a6c
Autor:
Ivette Mendoza-Salazar, Keyla M. Gómez-Castellano, Edith González-González, Ramsés Gamboa-Suasnavart, Stefany D. Rodríguez-Luna, Giovanni Santiago-Casas, María I. Cortés-Paniagua, Sonia M. Pérez-Tapia, Juan C. Almagro
Publikováno v:
Antibodies, Vol 11, Iss 1, p 13 (2022)
This report describes the discovery and characterization of antibodies with potential broad SARS-CoV-2 neutralization profiles. The antibodies were obtained from a phage display library built with the VH repertoire of a convalescent COVID-19 patient
Externí odkaz:
https://doaj.org/article/b8a1bc516d0b414ebdc11020455285b8
Autor:
Rosa Camacho-Sandoval, Alejandro Nieto-Patlán, Gregorio Carballo-Uicab, Alejandra Montes-Luna, María C. Jiménez-Martínez, Luis Vallejo-Castillo, Edith González-González, Hugo Iván Arrieta-Oliva, Keyla Gómez-Castellano, Omar U. Guzmán-Bringas, María Pilar Cruz-Domínguez, Gabriela Medina, Laura A. Montiel-Cervantes, Maricela Gordillo-Marín, Roberto Vázquez-Campuzano, Belem Torres-Longoria, Irma López-Martínez, Sonia M. Pérez-Tapia, Juan Carlos Almagro
Publikováno v:
Diagnostics, Vol 11, Iss 8, p 1506 (2021)
The implementation and validation of anti-SARS-CoV-2 IgG serological assays are reported in this paper. S1 and RBD proteins were used to coat ELISA plates, and several secondary antibodies served as reporters. The assays were initially validated with
Externí odkaz:
https://doaj.org/article/4a657da22e8345dfb8ddf5ffac0a94c4
Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons
Autor:
Ignacio Mejía-Calvo, Leslie Muñoz-García, Alexis Jiménez-Uribe, Rosa Camacho-Sandoval, Edith González-González, Gabriela Mellado-Sánchez, Alejandra V. Tenorio-Calvo, Carlos A. López-Morales, Marco A. Velasco-Velázquez, Lenin Pavón, Sonia Mayra Pérez-Tapia, Emilio Medina-Rivero
Publikováno v:
Biotechnology Reports, Vol 22, Iss , Pp - (2019)
The biotherapeutic type I interferons (IFN-I) are indicated to treat several diseases. These products are regulated to guarantee safety and efficacy through critical quality attributes. For this purpose, the development of robust assays is required,
Externí odkaz:
https://doaj.org/article/a7c434488f9c40d6be52806d7160617a
Autor:
Omar U. Guzmán-Bringas, Keyla M. Gómez-Castellano, Edith González-González, Juana Salinas-Trujano, Said Vázquez-Leyva, Luis Vallejo-Castillo, Sonia M. Pérez-Tapia, Juan C. Almagro
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 5
Pages: 4609
Volume 24
Issue 5
Pages: 4609
We recently reported the isolation and characterization of anti-SARS-CoV-2 antibodies from a phage display library built with the VH repertoire of a convalescent COVID-19 patient, paired with four naïve synthetic VL libraries. One of the antibodies,
Autor:
Gregorio Carballo-Uicab, Juan Carlos Almagro, Gabriela Medina, Laura Montiel-Cervantes, Alejandro Nieto-Patlán, Luis Vallejo-Castillo, Irma López-Martínez, Alejandra Montes-Luna, Maria C. Jiménez-Martínez, Roberto Vázquez-Campuzano, Keyla M. Gómez-Castellano, Hugo Iván Arrieta-Oliva, Rosa Camacho-Sandoval, Edith González-González, Omar U. Guzmán-Bringas, María Pilar Cruz-Domínguez, Sonia Mayra Pérez-Tapia, Belem Torres-Longoria, Maricela Gordillo-Marín
Publikováno v:
Diagnostics, Vol 11, Iss 1506, p 1506 (2021)
Diagnostics
Volume 11
Issue 8
Diagnostics
Volume 11
Issue 8
The implementation and validation of anti-SARS-CoV-2 IgG serological assays are reported in this paper. S1 and RBD proteins were used to coat ELISA plates, and several secondary antibodies served as reporters. The assays were initially validated with
Autor:
Carlos A. López-Morales, Marco A. Velasco-Velázquez, Jazmín Sánchez-Morales, Rosa Camacho-Sandoval, Leslie Muñoz-García, Alejandra V. Tenorio-Calvo, Sonia Mayra Pérez-Tapia, Edith González-González, Alexis Jiménez-Uribe, Ilselena Cortés-Paniagua, Emilio Medina-Rivero, Alejandra Montes-Luna, Lenin Pavón
Publikováno v:
Journal of Immunological Methods. 464:87-94
The development of biotherapeutics requires continuous improvement in analytical methodologies for the assessment of their quality attributes. A subset of biotherapeutics is designed to interact with specific antigens that are exposed on the membrane
Autor:
Rosa Camacho-Sandoval, Carlos A. López-Morales, Sonia Mayra Pérez-Tapia, Edith González-González, Marco A. Velasco-Velázquez, Emilio Medina-Rivero, Eréndira N. Sosa-Grande, Lenin Pavón-Romero, Alejandra V. Tenorio-Calvo
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 155
Physicochemical and structural properties of proteins used as active pharmaceutical ingredients of biopharmaceuticals are determinant to carry out their biological activity. In this regard, the assays intended to evaluate functionality of biopharmace